
Bilclav 250 mg/125 mg Tablet
Out of Stock • people bought this
Delivery : 2-4 days PAN India
Seller : Davadost pharma private limited
People who purchased Bilclav 250 mg/125 mg Tablet also bought
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Bilclav 250 mg/125 mg Tablet
Clavam 625 mg Tablet is a combination antibiotic used to treat a variety of bacterial infections. It contains two active ingredients, Amoxicillin and Clavulanic Acid, which work synergistically to eliminate bacterial infections that are resistant to antibiotics.
How Bilclav 250 mg/125 mg Tablet works
It is an antibiotic in which active ingredients Clavulanic acid and Amoxycillin are present. Amoxicillin: A broad-spectrum penicillin antibiotic that inhibits the growth of bacteria by interfering with their cell wall formation. Clavulanic Acid: A beta-lactamase inhibitor that protects Amoxicillin from degradation by beta-lactamase enzymes produced by certain resistant bacteria, enhancing the antibiotic's effectiveness.
How To Use Bilclav 250 mg/125 mg Tablet
- Dosage and Duration should always be taken as per doctor's advice.
- This medicine is taken after eating food.
Special Precautions for Bilclav 250 mg/125 mg Tablet
- Monitor liver and kidney function regularly during prolonged therapy
- Watch for signs of allergic reactions or gastrointestinal disturbances and report them to your doctor.
- It should be cautiously in patients with a history of penicillin allergy, liver dysfunction, or severe renal impairment.
Benefits Of Bilclav 250 mg/125 mg Tablet
- It shows an antibacterial activity effective in fight against bacterial infections.
- It can be used effectively in the treatment of tuberculosis.
- It blocks the enzyme and kills the bacteria.
Side Effects Of Bilclav 250 mg/125 mg Tablet
- Allergy
- Abdominal pain
- Vomiting
- Diarrhea
- Mucocutaneous candidiasis
What If I Missed A Dose Of Bilclav 250 mg/125 mg Tablet
- Use the medicine as you remember to take.
- If the next dose is near then skip the missed dose.
- Do not double up for the missed dose.
- If you miss a dose frequently then consult your doctor.
Health And Lifestyle
Drug Interaction
- Vitmain K antagonist- Warfarin
- Antimetabolite- Methotrexate
- Immunosuppresant- Mycophenolate mofetil
Drug Food Interaction
- Avoid high-fiber meals, as they may interfere with enzyme activity.
Disease Explanation

Bacterial infection is a condition in which harmful bacteria enter your body and start to multiply, causing illness and related symptoms like fever, pain, and swelling. It affects different parts of the body like ear, nose, throat, chest, lungs, teeth, skin, and urinary tract.
Safety Advice for Bilclav 250 mg/125 mg Tablet
- High risk
- Moderate risk
- Safe
It should be used with caution in patients with liver disease. Dose adjustment of medicine may be required. Please consult your doctor.
Exercise caution when using it in individuals with kidney disease. Dose adjustment may be required, so it's crucial to seek advise from a healthcare professional.
Effect of consumption of alcohol with this drug is unknown. Please consult your doctor.
It doesn’t hamper attention and thus is considered safe for activities requiring attention like driving.
It is generally considered safe during pregnancy, however seek advice from your doctor before starting the medication.
It is generally considered safe while you’re breastfeeding, consult your doctor for more specific information.
FAQ's on Bilclav 250 mg/125 mg Tablet
Can the use of Bilclav cause contraceptive failure?
What are the instructions for the storage and disposal of Bilclav?
Can I take a higher than the recommended dose of Bilclav?
Are there any specific cautions associated with the use of Bilclav?
Can I stop taking Bilclav when my symptoms are relieved?
Can the use of Bilclav cause diarrhea?
Can Bilclav cause an allergic reaction?
What is Bilclav?
Is it safe to use Bilclav?
Written By
Salony Priya
MBA in pharmaceutical management
Content Updated on
Friday, 17 January, 2025









